240 related articles for article (PubMed ID: 20054870)
1. Progenitor-derived hepatocellular carcinoma model in the rat.
Andersen JB; Loi R; Perra A; Factor VM; Ledda-Columbano GM; Columbano A; Thorgeirsson SS
Hepatology; 2010 Apr; 51(4):1401-9. PubMed ID: 20054870
[TBL] [Abstract][Full Text] [Related]
2. The correlation between poor prognosis and increased yes-associated protein 1 expression in keratin 19 expressing hepatocellular carcinomas and cholangiocarcinomas.
Lee K; Lee KB; Jung HY; Yi NJ; Lee KW; Suh KS; Jang JJ
BMC Cancer; 2017 Jun; 17(1):441. PubMed ID: 28645247
[TBL] [Abstract][Full Text] [Related]
3. CK19 and Glypican 3 Expression Profiling in the Prognostic Indication for Patients with HCC after Surgical Resection.
Feng J; Zhu R; Chang C; Yu L; Cao F; Zhu G; Chen F; Xia H; Lv F; Zhang S; Sun L
PLoS One; 2016; 11(3):e0151501. PubMed ID: 26977595
[TBL] [Abstract][Full Text] [Related]
4. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin.
Durnez A; Verslype C; Nevens F; Fevery J; Aerts R; Pirenne J; Lesaffre E; Libbrecht L; Desmet V; Roskams T
Histopathology; 2006 Aug; 49(2):138-51. PubMed ID: 16879391
[TBL] [Abstract][Full Text] [Related]
5. Role of p53 and β-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma.
Yuan RH; Jeng YM; Hu RH; Lai PL; Lee PH; Cheng CC; Hsu HC
J Gastrointest Surg; 2011 Feb; 15(2):321-9. PubMed ID: 21061181
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma.
Shibuya M; Kondo F; Sano K; Takada T; Asano T
J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):537-43. PubMed ID: 21234612
[TBL] [Abstract][Full Text] [Related]
7. Combination with CK19 Might Increase the Prognostic Power of Hep Par 1 in Hepatocellular Carcinoma after Curative Resection.
Jin Y; Liang ZY; Zhou WX; Zhou L
J Invest Surg; 2018 Oct; 31(5):412-419. PubMed ID: 28758812
[TBL] [Abstract][Full Text] [Related]
8. Immunohistologic attempt to find carcinogenesis from hepatic progenitor cell in hepatocellular carcinoma.
Yamamoto T; Uenishi T; Ogawa M; Ichikawa T; Hai S; Sakabe K; Tanaka S; Kato H; Mikami S; Ikebe T; Tanaka H; Ito S; Kaneda K; Hirohashi K; Kubo S
Dig Surg; 2005; 22(5):364-70. PubMed ID: 16374007
[TBL] [Abstract][Full Text] [Related]
9. Integrating single-cell and bulk RNA sequencing reveals CK19 + cancer stem cells and their specific SPP1 + tumor-associated macrophage niche in HBV-related hepatocellular carcinoma.
Yang CL; Song R; Hu JW; Huang JT; Li NN; Ni HH; Li YK; Zhang J; Lu Z; Zhou M; Wang JD; Li MJ; Zhan GH; Peng T; Yu HP; Qi LN; Wang QY; Xiang BD
Hepatol Int; 2024 Feb; 18(1):73-90. PubMed ID: 38159218
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic value of absent ductular reaction at hepatocellular-stromal boundaries in early stage hepatocellular carcinoma].
Zhang Q; Ma Z; Xin Q; Liu GQ; Liu BB; Gao YT; Zhang CS; Du Z
Zhonghua Gan Zang Bing Za Zhi; 2013 Dec; 21(12):924-8. PubMed ID: 24636295
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of tumor vascularity and its relationship to cytokeratin 19 expression in patients with hepatocellular carcinoma.
Chung GE; Lee JH; Yoon JH; Myung SJ; Lee K; Jang JJ; Lee JM; Kim SH; Suh KS; Kim YJ; Lee HS
Abdom Imaging; 2012 Jun; 37(3):439-46. PubMed ID: 21584634
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic implication of hepatic progenitor cell marker expression in hepatoblastoma.
Yun WJ; Shin E; Lee K; Jung HY; Kim SH; Park YN; Yu E; Jang JJ
Pathol Res Pract; 2013 Sep; 209(9):568-73. PubMed ID: 23920322
[TBL] [Abstract][Full Text] [Related]
13. [CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].
Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY; Hu WY; Han B
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):753-8. PubMed ID: 23291069
[TBL] [Abstract][Full Text] [Related]
14. Imaging Features of Gadoxetic Acid-enhanced and Diffusion-weighted MR Imaging for Identifying Cytokeratin 19-positive Hepatocellular Carcinoma: A Retrospective Observational Study.
Choi SY; Kim SH; Park CK; Min JH; Lee JE; Choi YH; Lee BR
Radiology; 2018 Mar; 286(3):897-908. PubMed ID: 29166246
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of hepatocellular carcinoma expressing cytokeratin 19: comparison with other liver cancers.
Lee JI; Lee JW; Kim JM; Kim JK; Chung HJ; Kim YS
World J Gastroenterol; 2012 Sep; 18(34):4751-7. PubMed ID: 23002345
[TBL] [Abstract][Full Text] [Related]
16. The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib.
Zhuo J; Lu D; Lin Z; Yang X; Yang M; Wang J; Tao Y; Wen X; Li H; Lian Z; Cen B; Dong S; Wei X; Xie H; Zheng S; Shen Y; Xu X
Cell Death Dis; 2021 Nov; 12(12):1084. PubMed ID: 34785656
[TBL] [Abstract][Full Text] [Related]
17. Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation.
Miltiadous O; Sia D; Hoshida Y; Fiel MI; Harrington AN; Thung SN; Tan PS; Dong H; Revill K; Chang CY; Roayaie S; Byrne TJ; Mazzaferro V; Rakela J; Florman S; Schwartz M; Llovet JM
J Hepatol; 2015 Dec; 63(6):1368-77. PubMed ID: 26220754
[TBL] [Abstract][Full Text] [Related]
18. Mixed phenotype hepatocellular carcinoma after transarterial chemoembolization and liver transplantation.
Zen C; Zen Y; Mitry RR; Corbeil D; Karbanová J; O'Grady J; Karani J; Kane P; Heaton N; Portmann BC; Quaglia A
Liver Transpl; 2011 Aug; 17(8):943-54. PubMed ID: 21491582
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cells in hepatocellular carcinoma--an immunohistochemical study with histopathological association.
Matthai SM; Ramakrishna B
Indian J Med Res; 2015 Oct; 142(4):391-8. PubMed ID: 26609030
[TBL] [Abstract][Full Text] [Related]
20. Genetic alterations and expression of PTEN and its relationship with cancer stem cell markers to investigate pathogenesis and to evaluate prognosis in hepatocellular carcinoma.
Chen D; Li Z; Cheng Q; Wang Y; Qian L; Gao J; Zhu JY
J Clin Pathol; 2019 Sep; 72(9):588-596. PubMed ID: 31126975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
